GPT and type 2 diabetes mellitus: Within an independent dataset of 447,486 individuals of the UK Biobank who were genotyped, but not imaged, individuals in the top 5% of the GFATadj polygenic score had higher HDL-cholesterol (beta: 0.16 SD; 95% CI: 0.15–0.18; p = 8.2 × 10−107), lower serum triglycerides (beta: −0.16 SD; 95% CI: −0.18–−0.15; p = 1.9 × 10−120), lower serum ALT (beta: −0.09; 95% CI: −0.10–−0.07; p = 7.9 × 10−36), lower risk of type 2 diabetes (OR: 0.75; 95% CI: 0.70–0.79; p = 1.3 × 10−23), and lower risk of coronary artery disease (OR: 0.89; 95% CI: 0.85–0.93; p = 1.6 × 10−6).